Category: MEMBER NEWS

The team at RetroSense Therapeutics, seasoned veterans with experience taking medical technology from the discovery stage to the clinic, knew 2016 could be a breakout year for the company.  RetroSense’s therapy, based on research conducted at Wayne State University in Detroit, was almost ready for its biggest test yet: a Phase I/II clinical trial.  In […]

Finding drugs to improve the quality of life for patients with endocrine diseases with few or no treatment options, can be a noble but resource-intensive task.  For Ann Arbor-based Millendo Therapeutics, a $62 million Series B financing announced in January 2016 moved the biotechnology company a little closer to that goal and earned it the […]

It’s MVCA Events & Program Manager, Molly Theis, here to encourage you to stay involved in the community in 2016!  MVCA would like to keep you “in the know” regarding the various events going on in the Entrepreneurial & Investment Community.  We not only want you to attend our MVCA Events, but also events hosted by your […]

For Detroit-based venture firm Fontinalis Partners, next generation mobility (i.e., “the efficient movement of goods, people, and services across all modes of transportation”) isn’t just an investment sector focus, it’s a way of life. So when the team chose a headquarters location for their firm in 2009, an investment thesis centered on innovating mobility led […]

Will Help Advance HistoSonics’ Non-Invasive Therapy Technology in Liver Tumors, Other High-Value Applications    Ann Arbor, MI – September 13, 2016 – HistoSonics, Inc. announced today that noted radiologist and tumor ablation expert Fred Lee, Jr., MD, has joined the company as Senior Medical Advisor and Board member to advance HistoSonics’ innovative tissue-destruction technology in liver […]

House Tax Policy Committee Chairman, Jeff Farrington (R-30) wasted no time getting a hearing on two bills that make up an Angel Investment Program he introduced during the one day this summer that the House was in session.  He quickly moved to have House Bills 5786 and 5787 placed in his committee to shepherd them […]

DUBLIN and ANN ARBOR, Mich., Sept. 6, 2016,– Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and RetroSense Therapeutics LLC, a Michigan Angel-backed, clinical-stage biotechnology company focused on novel gene therapy approaches to restore vision in patients suffering from blindness, today announced that Allergan has acquired substantially all of the assets of RetroSense in an all-cash transaction. Under the terms of the transaction, Allergan has […]

MVCA Member, Plymouth Ventures (“Plymouth”), announced yesterday, August 23, 2016, that it sold its position in 365 Retail Markets, the global leader in MicroMarket technology, to McCarthy Capital Fund VI (“McCarthy Capital”). McCarthy Capital manages more than $1 billion of investment capital across its portfolio. Headquartered in Troy, MI with offices in Santa Clara, CA, […]

MVCA Fellow Kathryn Gardner’s transition from investment banking to venture capital has been a smooth one, thanks in part of the experiences she’s had working at Michigan’s largest healthcare venture investor, Arboretum Ventures.  In the two years since Gardner joined the firm, the firm has raised $220 million to invest into healthcare companies in Michigan […]

Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease, and NAFLD/NASH (nonalcoholic fatty liver disease) today announced the pricing of its initial public offering. The shares are expected to begin trading on the […]